ARTICLE | Clinical News
Zyngenia preclinical data
March 18, 2013 7:00 AM UTC
In a mouse xenograft model of pancreatic cancer, Zyngenia's cetuximab-based bispecific zybody targeting EGFR and epidermal growth factor receptor 3 ( EGFR3; HER3; ErbB3) significantly inhibited tu...